PolyRisk+
The Broadest, Cutting-edge, AI-powered, Polygenic Panel for Full-Body Risk Assessment
Enabling full-body risk profiling across eight major disease categories
Why Broad Polygenic Risk Profiling Matters?
Most chronic diseases are driven by complex interactions between multiple genes – not just single mutations. Traditional panels often focus narrowly on monogenic or limited disease areas, missing the bigger picture1,2.
PolyRisk+ offers the most comprehensive polygenic panel available, covering over 30 complex conditions across eight major disease categories – extending well beyond traditional cardiometabolic and cancer profiling. Designed for early risk stratification and personalized prevention, PolyRisk+ empowers clinicians to guide interpretation and integrate results into care plans – shifting from reactive care to proactive prevention.*
*Physician-ordered tests are available only through healthcare providers.
What is PolyRisk+
PolyRisk+ is the most comprehensive AI-powered polygenic risk panel available today. It assesses genetic susceptibility across eight key disease areas:
What It Covers:
- CardioRisk+: CAD, Hypercholesterolemia, Hypertension, Type 2 diabetes, Obesity, AF, MASLD, CKD, VTE
- CancerRisk+: Colorectal, Prostate (men), breast & ovarian (women), melanoma, lung
- AutoimmuneRisk+: Psoriasis, Rheumatoid Arthritis, Celiac, Multiple Sclerosis, SLE, Ulcerative Colitis
- NeuroRisk+: Alzheimer’s, Parkinson’s
- MentalHealthRisk+: Bipolar Disorder, Schizophrenia
- RespiratoryRisk+: Asthma, Lung cancer
- WomenHealthRisk+: Osteoporosis, Breast Cancer, Ovarian cancer
- EyeRisk+: Intraocular pressure, POAG, AMD
Key Advantages of TotalRisk+
AI-powered insights
that combine polygenic risk scores with clinical context
Broader coverage
spanning 30+ complex conditions across eight major disease areas
Seamless integration
to support tailored care plans & proactive prevention
Clinician-led testing
for personalized prevention and treatment
Our Collaborators
Try the Most Comprehensive AI-powered Polygenic Risk Panel
References:
- Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018). The personal and clinical utility of polygenic risk scores. Nature Reviews Genetics, 19(9), 581–590. https://doi.org/10.1038/s41576-018-0018-x.
- Lewis, C. M., & Vassos, E. (2020). Polygenic risk scores: From research tools to clinical instruments. Genome Medicine, 12(1), 44. https://doi.org/10.1186/s13073-020-00742-5.